UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 55

Sortiert nach

Targeting PDGF‐mediated recruitment of pericytes blocks vascular mimicry and tumor growth

The Journal of pathology, 2018-12, Vol.246 (4), p.447-458

2018

Volltextzugriff (PDF)

Breast Cancer Prognosis and Occult Lymph Node Metastases, Isolated Tumor Cells, and Micrometastases

JNCI : Journal of the National Cancer Institute, 2010-03, Vol.102 (6), p.410-425

2010

Volltextzugriff (PDF)

Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer

Human reproduction (Oxford), 2014-05, Vol.29 (5), p.1103-1112

2014

Volltextzugriff (PDF)

The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic review

Insights into imaging, 2013-04, Vol.4 (2), p.163-175

2013

Volltextzugriff (PDF)

Multicenter Validation of a Gene Expression–Based Prognostic Signature in Lymph Node–Negative Primary Breast Cancer

Journal of clinical oncology, 2006-04, Vol.24 (11), p.1665-1671

2006

Volltextzugriff (PDF)

Support needs of couples with hereditary breast and ovarian cancer during reproductive decision making

Psycho-oncology (Chichester, England), 2018-07, Vol.27 (7), p.1795-1801

2018

Volltextzugriff (PDF)

Real-world and trial-based cost-effectiveness analysis of bevacizumab in HER2-negative metastatic breast cancer patients: a study of the Southeast Netherlands Breast Cancer Consortium

European journal of cancer (1990), 2017-07, Vol.79, p.238-246

2017

Volltextzugriff (PDF)

Oncologic management of ampullary cancer: International survey among surgical and medical oncologists

Surgical oncology, 2022-09, Vol.44, p.101841-101841, Article 101841

2022

Volltextzugriff (PDF)

EORTC Cancer in the Elderly Task Force guidelines for the use of colony-stimulating factors in elderly patients with cancer

European journal of cancer (1990), 2003-11, Vol.39 (16), p.2264-2272

2003

Volltextzugriff (PDF)

Survivin Is an Independent Prognostic Marker for Risk Stratification of Breast Cancer Patients

Clinical chemistry (Baltimore, Md.), 2004-11, Vol.50 (11), p.1986-1993

2004

Volltextzugriff (PDF)

ADAMTS8 and ADAMTS15 expression predicts survival in human breast carcinoma

International journal of cancer, 2006-03, Vol.118 (5), p.1241-1247

2006

Volltextzugriff (PDF)

FDG-PET in staging lung cancer: How does it change the algorithm?

Lung cancer (Amsterdam, Netherlands), 2004-05, Vol.44 (2), p.175-181

2004

Volltextzugriff (PDF)

Vascular endothelial growth factor is associated with the efficacy of endocrine therapy in patients with advanced breast carcinoma

Cancer, 2003-11, Vol.98 (10), p.2125-2132

2003

Volltextzugriff (PDF)

Cyclin-E is a strong predictor of endocrine therapy failure in human breast cancer

Oncogene, 2003-07, Vol.22 (31), p.4898-4904

2003

Volltextzugriff (PDF)

Abstract P2-01-04: Use of axillary ultrasound impacts outcome of node positive breast cancer patients

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P2-P2-01-04

2017

Volltextzugriff (PDF)

Abstract P2-01-03: What to do with non-visualized sentinel nodes; to dissect or not to dissect the axilla?

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P2-P2-01-03

2017

Volltextzugriff (PDF)

Standard Versus Intensified Chemotherapy With Granulocyte Colony-Stimulating Factor Support in Small-Cell Lung Cancer: A Prospective European Organization for Research and Treatment of Cancer–Lung Cancer Group Phase III Trial—08923

Journal of clinical oncology, 2002-10, Vol.20 (19), p.3947-3955

2002

Volltextzugriff (PDF)

Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: An EORTC double-blind placebo-controlled phase III study

Annals of oncology, 2001-10, Vol.12 (10), p.1359-1368

2001

Volltextzugriff (PDF)

Prognostic relevance of uPAR-del4/5 and TIMP-3 mRNA expression levels in breast cancer

European journal of cancer (1990), 2005-11, Vol.41 (17), p.2760-2768

2005

Volltextzugriff (PDF)

Carboplatin and paclitaxol (Taxol) as an induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer: an EORTC phase II study (EORTC 08958)

European journal of cancer (1990), 2003-07, Vol.39 (10), p.1416-1422

2003

Volltextzugriff (PDF)

Tissue inhibitors of metalloproteinase expression in human breast cancer: TIMP-3 is associated with adjuvant endocrine therapy success

The Journal of pathology, 2004-04, Vol.202 (4), p.395-402

2004

Volltextzugriff (PDF)

Complex of urokinase‐type plasminogen activator with its type 1 inhibitor predicts poor outcome in 576 patients with lymph node–negative breast carcinoma

Cancer, 2004-08, Vol.101 (3), p.486-494

2004

Volltextzugriff (PDF)

Predictive impact of urokinase-type plasminogen activator: Plasminogen activator inhibitor type-1 complex on the efficacy of adjuvant systemic therapy in primary breast cancer

Cancer research (Chicago, Ill.), 2004-01, Vol.64 (2), p.659-664

2004

Volltextzugriff (PDF)

Abstract OT2-07-08: Substantially improving the cure rate of high-risk BRCA1-like breast cancer patients with personalized therapy (SUBITO) - an international randomized phase III trial

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.OT2-07-08-OT2-07-08

2018

Volltextzugriff (PDF)

Micro-metastases in axillary lymph nodes: an increasing classification and treatment dilemma in breast cancer due to the introduction of the sentinel lymph node procedure

Breast cancer research and treatment, 2001-11, Vol.70 (2), p.81-88

2001

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(55)

Sprache

Englisch
(55)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Targeting PDGF‐mediated recruitment of pericytes blocks vascular mimicry and tumor growth

Breast Cancer Prognosis and Occult Lymph Node Metastases, Isolated Tumor Cells, and Micrometastases

Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer

The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic review

Multicenter Validation of a Gene Expression–Based Prognostic Signature in Lymph Node–Negative Primary Breast Cancer

Support needs of couples with hereditary breast and ovarian cancer during reproductive decision making

Real-world and trial-based cost-effectiveness analysis of bevacizumab in HER2-negative metastatic breast cancer patients: a study of the Southeast Netherlands Breast Cancer Consortium

Oncologic management of ampullary cancer: International survey among surgical and medical oncologists

EORTC Cancer in the Elderly Task Force guidelines for the use of colony-stimulating factors in elderly patients with cancer

Survivin Is an Independent Prognostic Marker for Risk Stratification of Breast Cancer Patients

ADAMTS8 and ADAMTS15 expression predicts survival in human breast carcinoma

FDG-PET in staging lung cancer: How does it change the algorithm?

Vascular endothelial growth factor is associated with the efficacy of endocrine therapy in patients with advanced breast carcinoma

Cyclin-E is a strong predictor of endocrine therapy failure in human breast cancer

Abstract P2-01-04: Use of axillary ultrasound impacts outcome of node positive breast cancer patients

Abstract P2-01-03: What to do with non-visualized sentinel nodes; to dissect or not to dissect the axilla?

Standard Versus Intensified Chemotherapy With Granulocyte Colony-Stimulating Factor Support in Small-Cell Lung Cancer: A Prospective European Organization for Research and Treatment of Cancer–Lung Cancer Group Phase III Trial—08923

Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: An EORTC double-blind placebo-controlled phase III study

Prognostic relevance of uPAR-del4/5 and TIMP-3 mRNA expression levels in breast cancer

Carboplatin and paclitaxol (Taxol) as an induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer: an EORTC phase II study (EORTC 08958)

Tissue inhibitors of metalloproteinase expression in human breast cancer: TIMP-3 is associated with adjuvant endocrine therapy success

Complex of urokinase‐type plasminogen activator with its type 1 inhibitor predicts poor outcome in 576 patients with lymph node–negative breast carcinoma

Predictive impact of urokinase-type plasminogen activator: Plasminogen activator inhibitor type-1 complex on the efficacy of adjuvant systemic therapy in primary breast cancer

Abstract OT2-07-08: Substantially improving the cure rate of high-risk BRCA1-like breast cancer patients with personalized therapy (SUBITO) - an international randomized phase III trial

Micro-metastases in axillary lymph nodes: an increasing classification and treatment dilemma in breast cancer due to the introduction of the sentinel lymph node procedure

Suchergebnisse filtern